Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03187106 · ClinicalTrials.gov registry record · Phase 1
Prophylactic Antibiotics After Cesarean
A Phase 1 study, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- Phase 1
- Development phase
- 321
- Enrollment target
NCT03187106 is a Phase 1 study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 321 participants.
The verdict
NCT03187106, a Phase 1 study, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 321 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the addition of a 48-hour course of post-operative antibiotics to the recommended course of pre-operative antibiotics improves surgical site infection rate in patients who are obese and undergo Cesarean section after laboring.
Interventions
- DRUG Placebo
- DRUG Metronidazole
- DRUG Cephalexin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 321 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2023-07-21 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03187106
The ClinicalTrials.gov registry entry for NCT03187106 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 321 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03187106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03187106 about?
NCT03187106 is a clinical study titled "Prophylactic Antibiotics After Cesarean". The purpose of this study is to determine if the addition of a 48-hour course of post-operative antibiotics to the recommended course of pre-operative antibiotics improves surgical site infection rate in patients who are obese and undergo Cesarean section after laboring.
What is the current status of trial NCT03187106?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 321 participants. The study started on 2017-08-01. Estimated completion is 2023-07-21.
What interventions are being tested in trial NCT03187106?
The interventions under investigation include: Placebo (DRUG), Metronidazole (DRUG), Cephalexin (DRUG).
Who is sponsoring clinical trial NCT03187106?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.